Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Tripep

1997 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
Description

Provider of biotechnology research services. The company's biotechnology research services focuses on the development and commercialization of candidate drugs based on patented technologies which includes development of a potential HIV-inhibiting drug, preclinical research focusing on the development of therapeutic and prophylactic vaccines against HIV and Hepatitis C and RAS technology platform.

Website
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • Hälsovägen 7
  • 141 57 Huddinge
  • Sweden
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Tripep’s full profile, request a free trial.

Tripep Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 25-Aug-2006 Completed Generating Revenue
3. PIPE 10-Nov-2003 Completed Generating Revenue
2. IPO 01-Jan-2000 Completed Generating Revenue
1. Early Stage VC Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Tripep Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
HealthCap Venture Capital Minority 000 0000 000000 0
Rolf Nordstrom Angel (individual) Minority 000 0000 000000 0

Tripep Executive Team (1)

Name Title Board
Seat
Contact
Info
Hans Möller Chief Executive Officer